Home › Calculator › IMDX Dividend Calculator 2026
IMDX Dividend Calculator 2026
No dividendHealthcareInsight Molecular Diagnostics Inc. · NASDAQ
Price: $2.83 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
IMDX is not a dividend-focused stock
IMDX pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
IMDX Dividend Yield
Insight Molecular Diagnostics Inc. (IMDX) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When IMDX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Insight Molecular Diagnostics Inc. (IMDX) — Dividend Analysis 2026
OncoCyte Corporation functions as a molecular diagnostics firm specializing in the research, development, and market introduction of distinctive, laboratory-developed tests aimed at cancer identification. Its operations span both the United States and international territories. The company's key offerings include DetermaRx, a molecular diagnostic tool tailored for detecting early-stage adenocarcinoma of the lung, and DetermaIO, a proprietary gene expression analysis. Additionally, OncoCyte provides a range of expert services, such as biomarker discovery, assay design and refinement, and clinical trial assistance, which encompass offering various biomarker tests to pharmaceutical partners. A strategic partnership with Life Technologies Corporation focuses on the collaborative development and commercialization of the Oncomine Comprehensive Assay Plus and Determa IO assay, intended for integration with the Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was founded in 2009 and maintains its principal office in Irvine, California.
IMDX Dividend & DRIP — Frequently Asked Questions
Does IMDX pay a dividend?
No. Insight Molecular Diagnostics Inc. (IMDX) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of IMDX?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does IMDX have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. IMDX has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to IMDX
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full IMDX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open IMDX position with:
🌍 IMDX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold IMDX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 IMDX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 IMDX Dividend Payment Schedule
IMDX pays quarterly — 4 times per year. Ex-div: —.
📊 IMDX vs Healthcare Benchmarks
How IMDX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for IMDX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ IMDX Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| F-InKind | 2026-07-01 | 7,700 | $5.69 | $43.8K | ||
| F-InKind | 2026-07-01 | 7,700 | $5.69 | $43.8K | ||
| F-InKind | 2026-07-01 | 12,100 | $5.69 | $68.8K | ||
| A-Award | 2026-06-11 | 26,943 | — | — | ||
| A-Award | 2026-06-11 | 26,943 | — | — | ||
| A-Award | 2026-06-11 | 32,331 | — | — | ||
| Buy | 2026-04-27 | 250,923 | $3.64 | $913.1K | ||
| Buy | 2026-04-24 | 38,880 | $3.53 | $137.1K | ||
| Buy | 2026-04-23 | 280,381 | $3.50 | $982.0K | ||
| Buy | 2026-04-20 | 40,690 | $3.88 | $158.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare IMDX with peers: IMDX vs ARMP · IMDX vs CCCC · IMDX vs CDXS
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where IMDX earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the IMDX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Insight Molecular Diagnostics Inc. (IMDX) is currently trading at $2.83, 67% below its 52-week high. It does not currently pay a regular dividend.
Does IMDX Pay a Dividend? Insight Molecular Diagnostics Inc. Dividend Status
Insight Molecular Diagnostics Inc. (IMDX) is a healthcare stock trading at $2.83. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest IMDX News
LiveProjected your IMDX DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.